PharmacoEconomics & Outcomes News

, Volume 813, Issue 1, pp 30–30 | Cite as

Therapy optimisation reduces cost of biologicals in Spain

Clinical study


  1. Gonzalez-Fernandez M, et al. Cost evolution of biological agents for the treatment of spondyloarthritis in a tertiary hospital: influential factors in price. International Journal of Clinical Pharmacy : 8 Sep 2018. Available from: URL:

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations